Answers are grounded in this paper and cite their sources.
Background: India has a significant burden of chronic respiratory diseases, many of which require long-term oxygen therapy (LTOT) for respiratory failure. Previous studies have shown poor compliance with LTOT, but data on quality of life (QOL) in patients receiving LTOT is limited. Methodology: This was a prospective observational study conducted at a tertiary care center. 56 patients with chronic respiratory failure who were prescribed LTOT were followed up for 6 months, and their QOL was assessed and compared to baseline. Results: Chronic obstructive pulmonary disease was the most common diagnosis (64%), followed by obstructive sleep apnea–obesity hypoventilation syndrome overlap (25%) and interstitial lung disease (20%). Most (77%) of the patients preferred getting an oxygen concentrator on a monthly rental basis, rather than purchasing one. LTOT compliance at 6 months was 44.4%, with reasons for discontinuation including financial constraints (31%), feeling better (28%), and doctor’s advice (24%). There was statistically significant improvement in QOL for patients who continued using oxygen at 6 months. Conclusion: LTOT improves QOL in patients with chronic respiratory diseases, irrespective of the hours of usage.
No takes yet. Share an insight, caveat, or question.
Singh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: